NRx Pharmaceuticals, Inc.NRXPNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank38
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-1.58
↑ 15% vs avg
Percentile
P38
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-1.86
Historical baseline
PeriodValueYoY Change
TTM-1.58+33.9%
2024-2.39+39.9%
2023-3.98-563.3%
2022-0.60+91.9%
2021-7.44-392.7%
2020-1.51-288.8%
20190.80+979.6%
20180.07+161.8%
2017-0.12-